Latest filing published 28 Jul 2026 for JW (Cayman) Therapeutics Co. Ltd - B, €8,488.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Tian Feng is a declared insider of JW (Cayman) Therapeutics Co. Ltd - B, with filings sourced from HKEX. We count 6 filings; the first trade dates from 16 January 2026 and the latest from 22 July 2026.
On the market, this insider has only ever bought: 6 purchases, €30k in total. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €8,131. Measured against the company's value, the median purchase equals 0.011% of market capitalisation, across 4 purchases where it is known. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The newest entry dates from 28 July 2026: an open-market purchase of €8,488, in JW (Cayman) Therapeutics Co. Ltd - B. Between a trade and the moment it shows up on HKEX, the median delay is 9 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations